Philip Morris InternationalWide moat

PM — overall economic moat

Investment snapshot
Wide moat→ Holding steadyConfidenceMediumValuationExpensive
Strongest advantageIQOS: about three-quarters of global heated tobacco, and an International Smoke-Free gross margin (68.4%) now above combustibles (66.2%)
Greatest threatThe American bet: about $19bn spent in 2022 on a U.S. business whose revenue fell 16% and adjusted income halved in H1 2026 as ZYN stalled
Key metricSmoke-free share of gross profit (nearly 43% in 2025)
Verdict: PMI has done what no other large tobacco company has: built a replacement for the cigarette that already earns a higher gross margin than the cigarette, and funded it with the cigarette's own cash. That is a wide moat, widening abroad. The American half of the transition, bought with Swedish Match, is weaker and stalled in 2026, and governments take more from each pack than PMI does. At about 27 times trailing earnings, with all growth to 2028 to come without buybacks, the shares price the transition as largely won.
📈 PM valuation, revenue & earnings — P/E, P/S, revenue, EPS →

Philip Morris International sells cigarettes outside the United States and the products it hopes will replace them. It is a Virginia holding company incorporated in 1987 that became a separate public company, listed on the New York Stock Exchange, when Altria spun it off in March 20081. It employed about 84,900 people at the end of 20252, and its cigarettes are sold in approximately 170 markets3.

Net revenues, excluding excise ($bn)26.8201528.7201729.8201931.4202135.2202340.62025PMI Forms 10-K FY2018 and FY2025; Swedish Match from Nov 2022
Flat for five years, then growing on smoke-free.

Net revenues were $40,648 million in 20254. That figure is net of excise tax, which PMI collected and passed on to governments: $53,211 million in 20255, more than the revenue PMI kept. Since January 2026 PMI reports three segments: International Combustibles, $23,436 million in 2025; International Smoke-Free, $13,996 million; and the U.S., $3,216 million6.

How it makes money has two halves. The first is the old one: Marlboro and other cigarettes, sold at prices that rise faster than volumes fall. The second is smoke-free products: IQOS heated tobacco abroad, where PMI holds about three-quarters of global volume7, ZYN nicotine pouches in the United States, bought with Swedish Match in 20228, and VEEV e-vapor. Smoke-free products were 41.5% of net revenues in 2025 and nearly 43% of gross profit9.

The business is very profitable and needs little capital. Gross profit was $27,282 million and operating income $14,892 million in 202510; net earnings attributable to PMI were $11,348 million, or $7.26 a diluted share, and $7.54 adjusted1112. Operating cash flow was $12,233 million against capital spending of $1,569 million13.

The balance sheet is leveraged by choice. Net debt was $43,963 million at the end of 202514, 2.35 times adjusted EBITDA by June 202615, and stockholders' equity is a deficit16. The dividend has risen every year since 2008 and is now $6.40 a year17. PMI plans no share repurchases18.

In the second quarter of 2026 net revenues rose 10.4% to $11,192 million19, with international smoke-free up 14.2% and the U.S. down 0.7%20. The shares were $190.48 on 25 September 2026, a market value of $296.88 billion21, 27.41 times trailing and 21.65 times forward earnings22.

PMI's owners are institutions. At 13 March 2026 Vanguard held 8.57% of the shares, Capital World Investors 8.17%, Capital International Investors 6.61% and BlackRock 6.22%23. There is a single class of stock and no controlling holder, so the dividend policy and the pace of the transition answer to a broad base of fund managers rather than to a family or a parent.

The moat is wide: a cigarette franchise that funds its own replacement, which already earns the higher margin. The number that would falsify that verdict is the smoke-free share of gross profit, nearly 43% in 202524; if it stops rising while cigarette volumes keep falling, the handover will have stalled with the old business still paying the bills.

The number that tests this moat
Reported
Revenue, and where it comes from
$40.6bn in 2025, net of $53.2bn of excise: International Combustibles $23.4bn, International Smoke-Free $14.0bn, U.S. $3.2bn

Smoke-free was 41.5% of revenue and nearly 43% of gross profit. Watch that share keep rising.

Source: PMI recast schedules 2025 vs 2024 ↗
Moat scorecardHow ratings work →
Switching costs7/10
Network effects1/10
Pricing power7/10
Hard to replicate8/10
Disruption resistance6/10
Overall durability8/10

Switching costs are high where PMI's device ties the consumer to its consumables, and nicotine loyalty is strong; pouches and cigarettes are easier to switch. Replication is hard: regulatory orders, scientific files and a decade of IQOS scale cannot be bought quickly. Pricing power is real in cigarettes but bounded by excise, which governments set and which already exceeds PMI's revenue. Disruption resistance is moderate: regulators can ban, tax or reclassify products, as India, Germany and Poland show. Network effects are minimal. Durability sits in the wide band because the replacement is already more profitable than the product it replaces.

Dig deeper
✦ Future bets — beyond today's moat
⚠ Threats to the moat
◆ What the market may be missing
References
  1. ReportedIt is a Virginia holding company incorporated in 1987 that became a separate public company, listed on the New York Stock Exchange, when Altria spun it off in March 2008.
    Philip Morris International Form 10-K for fiscal 2025 - Item 1 business: markets, products, competitors, market shares, shipments and employees. — FY2025 · publ. 6 February 2026 · source ↗
  2. ReportedIt employed about 84,900 people at the end of 2025, and its cigarettes are sold in approximately 170 markets.
    Philip Morris International Form 10-K for fiscal 2025 - Item 1 business: markets, products, competitors, market shares, shipments and employees. — FY2025 · publ. 6 February 2026 · source ↗
  3. ReportedIt employed about 84,900 people at the end of 2025, and its cigarettes are sold in approximately 170 markets.
    Philip Morris International Form 10-K for fiscal 2025 - Item 1 business: markets, products, competitors, market shares, shipments and employees. — FY2025 · publ. 6 February 2026 · source ↗
  4. ReportedNet revenues were $40,648 million in 2025.
    Philip Morris International Form 10-K for fiscal 2025 - financial statements and notes: income statement, excise, cash flow, debt, acquisitions and impairments. — FY2025 · publ. 6 February 2026 · source ↗
  5. ReportedThat figure is net of excise tax, which PMI collected and passed on to governments: $53,211 million in 2025, more than the revenue PMI kept.
    Philip Morris International Form 10-K for fiscal 2025 - financial statements and notes: income statement, excise, cash flow, debt, acquisitions and impairments. — FY2025 · publ. 6 February 2026 · source ↗
  6. ReportedSince January 2026 PMI reports three segments: International Combustibles, $23,436 million in 2025; International Smoke-Free, $13,996 million; and the U.S., $3,216 million.
    Philip Morris International Form 8-K exhibit 99.1 - 2025 and 2024 results recast into the new segments International Smoke-Free, International Combustibles and U.S. — FY2025 · publ. 13 March 2026 · source ↗
  7. ReportedThe second is smoke-free products: IQOS heated tobacco abroad, where PMI holds about three-quarters of global volume, ZYN nicotine pouches in the United States, bought with Swedish Match in 2022, and VEEV e-vapor.
    Philip Morris International second-quarter 2026 results release, Form 8-K exhibit 99.1 - volumes, shares, ZYN and 2026 guidance - shipment volumes, market shares, IQOS, ZYN and Japan. — Q2 2026 · publ. 22 July 2026 · source ↗
  8. ReportedThe second is smoke-free products: IQOS heated tobacco abroad, where PMI holds about three-quarters of global volume, ZYN nicotine pouches in the United States, bought with Swedish Match in 2022, and VEEV e-vapor.
    Philip Morris International Form 10-K for fiscal 2022 - the Swedish Match acquisition, the Vectura and Fertin Pharma purchases, and smoke-free revenue for 2021-2022. — FY2022 · publ. February 2023 · source ↗
  9. ReportedSmoke-free products were 41.5% of net revenues in 2025 and nearly 43% of gross profit.
    Philip Morris International fourth-quarter and full-year 2025 results release, Form 8-K exhibit 99.1 - smoke-free share of revenue and gross profit, 2026 guidance and 2026-2028 targets. — FY2025 · publ. 6 February 2026 · source ↗
  10. ReportedGross profit was $27,282 million and operating income $14,892 million in 2025; net earnings attributable to PMI were $11,348 million, or $7.26 a diluted share, and $7.54 adjusted.
    Philip Morris International Form 10-K for fiscal 2025 - financial statements and notes: income statement, excise, cash flow, debt, acquisitions and impairments. — FY2025 · publ. 6 February 2026 · source ↗
  11. ReportedGross profit was $27,282 million and operating income $14,892 million in 2025; net earnings attributable to PMI were $11,348 million, or $7.26 a diluted share, and $7.54 adjusted.
    Philip Morris International Form 10-K for fiscal 2025 - financial statements and notes: income statement, excise, cash flow, debt, acquisitions and impairments. — FY2025 · publ. 6 February 2026 · source ↗
  12. ReportedGross profit was $27,282 million and operating income $14,892 million in 2025; net earnings attributable to PMI were $11,348 million, or $7.26 a diluted share, and $7.54 adjusted.
    Philip Morris International fourth-quarter and full-year 2025 results release, Form 8-K exhibit 99.1 - smoke-free share of revenue and gross profit, 2026 guidance and 2026-2028 targets. — FY2025 · publ. 6 February 2026 · source ↗
  13. ReportedOperating cash flow was $12,233 million against capital spending of $1,569 million.
    Philip Morris International Form 10-K for fiscal 2025 - financial statements and notes: income statement, excise, cash flow, debt, acquisitions and impairments. — FY2025 · publ. 6 February 2026 · source ↗
  14. ReportedNet debt was $43,963 million at the end of 2025, 2.35 times adjusted EBITDA by June 2026, and stockholders' equity is a deficit.
    Philip Morris International Q4 2025 exhibit 99.2 - total debt, net debt, adjusted EBITDA and net debt to adjusted EBITDA. — FY2025 · publ. 6 February 2026 · source ↗
  15. ReportedNet debt was $43,963 million at the end of 2025, 2.35 times adjusted EBITDA by June 2026, and stockholders' equity is a deficit.
    Philip Morris International Q2 2026 exhibit 99.2 - non-GAAP schedules, operating cash flow and net debt to adjusted EBITDA. — Q2 2026 · publ. 22 July 2026 · source ↗
  16. ReportedNet debt was $43,963 million at the end of 2025, 2.35 times adjusted EBITDA by June 2026, and stockholders' equity is a deficit.
    Philip Morris International Form 10-K for fiscal 2025 - financial statements and notes: income statement, excise, cash flow, debt, acquisitions and impairments. — FY2025 · publ. 6 February 2026 · source ↗
  17. ReportedThe dividend has risen every year since 2008 and is now $6.40 a year.
    Philip Morris International dividend increase release, 18 September 2026. — September 2026 · publ. 18 September 2026 · source ↗
  18. ReportedPMI plans no share repurchases.
    Philip Morris International second-quarter 2026 results release, Form 8-K exhibit 99.1 - volumes, shares, ZYN and 2026 guidance - results, margins, operating companies income, cash and 2026 guidance. — Q2 2026 · publ. 22 July 2026 · source ↗
  19. ReportedIn the second quarter of 2026 net revenues rose 10.4% to $11,192 million, with international smoke-free up 14.2% and the U.S. down 0.7%.
    Philip Morris International Form 10-Q for the quarter ended 30 June 2026 - segment results, the balance sheet, FDA authorisations and shares outstanding. — Q2 2026 · publ. 24 July 2026 · source ↗
  20. ReportedIn the second quarter of 2026 net revenues rose 10.4% to $11,192 million, with international smoke-free up 14.2% and the U.S. down 0.7%.
    Philip Morris International Form 10-Q for the quarter ended 30 June 2026 - segment results, the balance sheet, FDA authorisations and shares outstanding. — Q2 2026 · publ. 24 July 2026 · source ↗
  21. ReportedThe shares were $190.48 on 25 September 2026, a market value of $296.88 billion, 27.41 times trailing and 21.65 times forward earnings.
    Philip Morris International (PM) market data - $190.48 a share at the close on 25 September 2026, market cap $296.88B, 52-week range 142.11-207.76, beta 0.40, 16 analysts with a consensus Buy rating and a price target of $208.13. — September 2026 · publ. 25 September 2026 · source ↗
  22. ReportedThe shares were $190.48 on 25 September 2026, a market value of $296.88 billion, 27.41 times trailing and 21.65 times forward earnings.
    Philip Morris International (PM) statistics - trailing P/E 27.41, forward P/E 21.65, P/S 6.98, negative book value, return on equity not meaningful, enterprise value $340.02B, EV/EBITDA 18.87, 52-week change +16.86%. — September 2026 · publ. 25 September 2026 · source ↗
  23. ReportedAt 13 March 2026 Vanguard held 8.57% of the shares, Capital World Investors 8.17%, Capital International Investors 6.61% and BlackRock 6.22%.
    Philip Morris International proxy statement (DEF 14A), 2026 - leadership, shareholders and executive pay. — 2026 · publ. 26 March 2026 · source ↗
  24. ReportedThe number that would falsify that verdict is the smoke-free share of gross profit, nearly 43% in 2025; if it stops rising while cigarette volumes keep falling, the handover will have stalled with the old business still paying the bills.
    Philip Morris International fourth-quarter and full-year 2025 results release, Form 8-K exhibit 99.1 - smoke-free share of revenue and gross profit, 2026 guidance and 2026-2028 targets. — FY2025 · publ. 6 February 2026 · source ↗
Sources
Generated September 26, 2026